产品名称

Lapatinib ditosylate - GW 572016

产品货号

Axon 1395 CAS [388082-77-7] MF C29H26ClFN4O4S.2C7H8O3SMW 925.46 Purity: 99% Soluble in DMSO Description An ATP-competitive epidermal growth factor receptor (EGFR) and HER2/neu (ErbB-2) dual tyrosine kinase inhibitor References Certificates Categories Extra info HA Burris. Dual kinase inhibition in the treatment of breast cancer: initial experience with the EGFR/ErbB-2 inhibitor lapatinib. Oncologist 2004, 9 Suppl 3: 10–5. MH Nelson, CR Dolder. Lapatinib: a novel dual tyrosine kinase inhibitor with activity in solid tumors. Ann Pharmacother 2006, 40(2), 261–9. Certificate of Analysis Material Safety Data Sheet Angiogenesis Cell Signaling & Oncology EGFR ErbB2-HER2 JAK-STAT RTK class I; EC 2.7.10.1 EGFR and ErbB-2/HER2 tyrosine kinase inhibitor Chemical name N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]-2-furyl] quinazolin-4-amine ditosylate Parent CAS No. [231277-92-2] Order Size Unit Price Stock 10 mg €95.00 In Stock

产品价格

现货询价，电话：010-67529703

产品规格

产品品牌

axonmedchem

产品概述

产品详情

Lapatinib ditosylate - GW 572016

Based on 16 reference(s) in Google Scholar 9 10 16

Axon 1395

CAS [388082-77-7]

MF C29H26ClFN4O4S.2C7H8O3S
MW 925.46

Purity: 99%
Soluble in DMSO

Lapatinib ditosylate

Description

An ATP-competitive epidermal growth factor receptor (EGFR) and HER2/neu (ErbB-2) dual tyrosine kinase inhibitor

HA Burris. Dual kinase inhibition in the treatment of breast cancer: initial experience with the EGFR/ErbB-2 inhibitor lapatinib. Oncologist 2004, 9 Suppl 3: 10–5.

MH Nelson, CR Dolder. Lapatinib: a novel dual tyrosine kinase inhibitor with activity in solid tumors. Ann Pharmacother 2006, 40(2), 261–9.

Angiogenesis Cell Signaling & Oncology EGFR ErbB2-HER2 JAK-STAT RTK class I; EC 2.7.10.1

EGFR and ErbB-2/HER2 tyrosine kinase inhibitor

Chemical name

N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]-2-furyl] quinazolin-4-amine ditosylate

Parent CAS No.

[231277-92-2]

产品资料